articles about mycoplasma in Press releases

Ceva receives EU marketing authorization granted by the EU Commission for Cirbloc^® M Hyo, a new Ready To Use vaccine to protect pigs against PCV2 and Mycoplasma hyopneumoniae

The new vaccine is based on the PCV2d genotype, the most circulating one in the field and on the Mycoplasma hyopneumoniae (M. hyo) strain BA 2940.

Home

HealthPress releases

Boehringer Ingelheim's TwistPak^® mixing platform for swine vaccines brings convenience and flexibility

TwistPak® allows for fresh mixing of Ingelvac CircoFLEX® and Ingelvac MycoFLEX® on farm in less than 5 seconds.

Home

HealthPress releases

University of Minnesota swine professors receive awards at CVM Research Day

Dr. Maria Pieters and Dr. Noelle Noyes receive awards at the Points of Pride Research Day of the UMN College of Veterinary Medicine.

Home

HealthPress releases

Ceva receives positive opinion from EMA for Circovac^® + Hyogen^® Ready to Mix: DUO™ swine vaccines

The combination of products gives protection against PCV2 and Mycoplasma hyopneumoniae until 26 weeks of age.

Home

HealthPress releases

Zoetis launches CircoMax^® Myco to deliver broader coverage against PCV2

Unique PCV2 and M. hyopneumoniae ready-to-use, single-dose combination vaccine on the market.

Home

HealthPress releases

Pharmgate: Aivlosin^® WSG approved in U.S. and Canada to control Mycoplasma hyopneumoniae

This approval gives Aivlosin^® WSG the broadest label indication of any product for the control of swine respiratory disease (SRD).

Home

HealthPress releases

Zoetis Receives European Commission Marketing Authorization for CircoMax^® Myco

First PCV2 and M. hyopneumoniae combination vaccine in the EU for pigs that includes two PCV2 genotypes for broader coverage against continuously evolving Porcine Circovirus.

Home

HealthPress releases

New Swine Claim for Lincomix® Provides Flexible Dosing for M. hyo

Now Lincomix® can be administered at 100 to 200 grams per ton of feed for 21 days to reduce the severity of respiratory disease associated with M. hyo.

Home

Press releases

Ceva enters European swine vaccine market with new, targeted vaccine to improve control of enzootic pneumonia

Experts meet in Barcelona to discuss new strategies to prevent the disease.

Home

Press releases

Controlling disease in young pigs

Mycoplasmal pneumonia and porcine circovirus are two of the costliest diseases affecting pork producers. Helping provide protection before disease exposure is critical to the success of any vaccination program.

Home

Press releases

RespiSure-ONE^® now registered for use in day old piglets

Canadian swine producers can now vaccinate for mycoplasma pneumonia when they process baby pigs. A new label claim makes RespiSure-ONE the only vaccine approved for administration at one day of age.

Home

Press releases

USGC consultant boosts Mycotoxin understanding in Taiwan

A Kansas State microbiology expert has completed an intense schedule of briefings in Taiwan in an outreach effort to update industry and government officials on mycotoxins.

Home

Press releases

New Fostera PCV is the only single-dose vaccine that helps prevent PCV2 viremia

Veterinarians and pork producers can now help prevent Porcine Circovirus Type 2 (PCV2) viremia with the convenience of a single dose. New Fostera™ PCV from Pfizer Animal Health is the result of the company's commitment to best practices and continuous quality improvements.

Home

Press releases

Day one Mycoplasma hyopneumoniae vaccination now possible with RespiSure-ONE®

Pork producers in US can now vaccinate for mycoplasmal pneumonia at day one.

Home

Press releases

Intervet/Schering-Plough animal health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swine

Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.

Home

Press releases

First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union

The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.